A (Agilent Technologies) Current Accrued Expense : $436 Mil (As of Jan. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Current Accrued Expense?

Agilent Technologies's Current Accrued Expense for the quarter that ended in Jan. 2025 was $436 Mil.

Agilent Technologies's quarterly Current Accrued Expense increased from Jul. 2024 ($264 Mil) to Oct. 2024 ($398 Mil) and increased from Oct. 2024 ($398 Mil) to Jan. 2025 ($436 Mil).

Agilent Technologies's annual Current Accrued Expense declined from Oct. 2022 ($329 Mil) to Oct. 2023 ($309 Mil) but then increased from Oct. 2023 ($309 Mil) to Oct. 2024 ($398 Mil).

Agilent Technologies Current Accrued Expense Historical Data

The historical data trend for Agilent Technologies's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Current Accrued Expense Chart

Agilent Technologies Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Current Accrued Expense

Get a 7-Day Free Trial

285.00

328.00

329.00

309.00

398.00

Agilent Technologies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Current Accrued Expense	Get a 7-Day Free Trial															335.00	218.00	264.00	398.00	436.00

Agilent Technologies Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Agilent Technologies Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

1A:Italy 0HAV:UK AG8:Germany AG8:Germany AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Executives

Daniel K Podolsky	director	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Rodney Gonsalves	officer: V.P., Corporate Controller	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Sue H. Rataj	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Padraig Mcdonnell	officer: Senior Vice President	5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051
Dominique Grau	officer: Senior Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Philip Binns	officer: Senior Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen	officer: CEO and President	5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
Heidi Fields	director	5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Henrik Ancher-jensen	officer: Sr. Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
George A Scangos	director	C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley	director	5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten	director	5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand	director	C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Dow R Wilson	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh	director	C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051